Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation (original) (raw)

• Alitalo, K., Tammela, T. & Petrova, T.V. Lymphangiogenesis in development and human disease. Nature 438, 946–953 (2005).
  Article CAS Google Scholar
• Mortimer, P.S. et al. The prevalence of arm oedema following treatment for breast cancer. Quart. J. Med. 89, 377–780 (1996).
  Article Google Scholar
• Clark, B., Sitzia, J. & Harlow, W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. Quart. J. Med. 98, 343–348 (2005).
  Article CAS Google Scholar
• Tabibiazar, R. et al. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 3, e254 (2006).
  Article Google Scholar
• Ferrell, R.E. et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 7, 2073–2078 (1998).
  Article CAS Google Scholar
• Irrthum, A., Karkkainen, M.J., Devriendt, K., Alitalo, K. & Vikkula, M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67, 295–301 (2000).
  Article CAS Google Scholar
• Karkkainen, M.J. et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25, 153–159 (2000).
  Article CAS Google Scholar
• Rockson, S.G. Lymphedema. Am. J. Med. 110, 288–295 (2001).
  Article CAS Google Scholar
• Baumeister, R.G., Seifert, J. & Hahn, D. Autotransplantation of lymphatic vessels. Lancet 1, 147 (1981).
  Article CAS Google Scholar
• Karkkainen, M.J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98, 12677–12682 (2001).
  Article CAS Google Scholar
• Szuba, A. et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16, 1985–1987 (2002).
  Article CAS Google Scholar
• Yoon, Y.S. et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111, 717–725 (2003).
  Article CAS Google Scholar
• Saaristo, A. et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 18, 1707–1709 (2004).
  Article CAS Google Scholar
• Ikomi, F. et al. Recanalization of the collecting lymphatics in rabbit hind leg. Microcirculation 13, 365–376 (2006).
  Article Google Scholar
• Saaristo, A. et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 196, 719–730 (2002).
  Article CAS Google Scholar
• Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511–2514 (1999).
  Article CAS Google Scholar
• Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789–801 (1999).
  Article CAS Google Scholar
• Wigle, J.T. & Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769–778 (1999).
  Article CAS Google Scholar
• Enholm, B. et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88, 623–629 (2001).
  Article CAS Google Scholar
• Rissanen, T.T. et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098–1106 (2003).
  Article CAS Google Scholar
• Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423–1425 (1997).
  Article CAS Google Scholar
• Veikkola, T. et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 6, 1223–1231 (2001).
  Article Google Scholar
• Karpanen, T. et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 169, 708–718 (2006).
  Article CAS Google Scholar
• Dor, Y. et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21, 1939–1947 (2002).
  Article CAS Google Scholar
• Pipp, F. et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92, 378–385 (2003).
  Article CAS Google Scholar
• Schaper, W. & Scholz, D. Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 23, 1143–1151 (2003).
  Article CAS Google Scholar
• Garcia-Cardena, G., Comander, J., Anderson, K.R., Blackman, B.R. & Gimbrone, M.A., Jr. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA 98, 4478–4485 (2001).
  Article CAS Google Scholar
• Ng, C.P., Helm, C.L. & Swartz, M.A. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68, 258–264 (2004).
  Article Google Scholar
• Ito, W.D. et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80, 829–837 (1997).
  Article CAS Google Scholar
• Arras, M. et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101, 40–50 (1998).
  Article CAS Google Scholar
• Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192–198 (2001).
  Article CAS Google Scholar
• Saaristo, A. et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169, 1080–1087 (2006).
  Article CAS Google Scholar
• Makinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes. Dev. 19, 397–410 (2005).
  Article Google Scholar
• Baluk, P. et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204, 2349–2362 (2007).
  Article CAS Google Scholar
• Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333–345 (2004).
  Article CAS Google Scholar
• Paik, J.H. et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes. Dev. 18, 2392–2403 (2004).
  Article CAS Google Scholar
• Armulik, A., Abramsson, A. & Betsholtz, C. Endothelial/pericyte interactions. Circ. Res. 97, 512–523 (2005).
  Article CAS Google Scholar
• Petrova, T.V. et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10, 974–981 (2004).
  Article CAS Google Scholar
• Mellor, R.H. et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 115, 1912–1920 (2007).
  Article CAS Google Scholar
• Mebius, R.E., Streeter, P.R., Breve, J., Duijvestijn, A.M. & Kraal, G. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J. Cell. Biol. 115, 85–95 (1991).
  Article CAS Google Scholar
• Rabson, J.A., Geyer, S.J., Levine, G., Swartz, W.M. & Futrell, J.W. Tumor immunity in rat lymph nodes following transplantation. Ann. Surg. 196, 92–99 (1982).
  Article CAS Google Scholar
• Becker, C., Assouad, J., Riquet, M. & Hidden, G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann. Surg. 243, 313–315 (2006).
  Article Google Scholar
• Vintersten, K. et al. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40, 241–246 (2004).
  Article CAS Google Scholar
• Kozaki, K. et al. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res. 60, 2535–2340 (2000).
  CAS PubMed Google Scholar
• He, Y. et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65, 4739–4746 (2005).
  Article CAS Google Scholar
• Harrell, M.I., Iritani, B.M. & Ruddell, A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 170, 774–786 (2007).
  Article Google Scholar
• Makinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762–4773 (2001).
  Article CAS Google Scholar
• Kriehuber, E. et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797–808 (2001).
  Article CAS Google Scholar
• Baluk, P. et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247–257 (2005).
  Article CAS Google Scholar
• Karkkainen, M.J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 5, 74–80 (2004).
  Article CAS Google Scholar